Results 201 to 210 of about 297,779 (263)

Therapeutic role of histone deacetylase inhibition in an in vitro model of Graves' orbitopathy. [PDF]

Mol Med Rep
Byeon HJ, Choi SH, Kikkawa DO, Ko J, Yoon JS.   +4 more
europepmc   +1 more source

Strabismus surgery in topical anaesthesia with intraoperative suture adjustment in Graves' orbitopathy. [PDF]

Acta Ophthalmol
Haugen OH, Mellgren AEC, Norli M, Ueland HO.   +3 more
europepmc   +1 more source

Concomitant Exacerbation of Graves Orbitopathy and Double-Seronegative Myasthenia Gravis after SARS-CoV-2 Infection. [PDF]

JCEM Case Rep
Nakano Y, Takeshima K, Furukawa Y, Morita S, Sakata M, Matsuoka TA.   +5 more
europepmc   +1 more source

Volumetric measurements in Graves’ orbitopathy

, 2010
openaire   +2 more sources

Some of the next articles are maybe not open access.

Related searches:

M1-Like Macrophages Modulate Fibrosis and Inflammation of Orbital Fibroblasts in Graves' Orbitopathy: Potential Relevance to Soluble Interleukin-6 Receptor

Thyroid, 2023
Background: Graves' orbitopathy (GO) is a disfiguring and sight-threatening autoimmune disease. Previous studies have shown the infiltration of macrophages in GO orbital connective tissues.
Yi Lu, Yi Wang, Yang Wang, Yu Wu, Yazhuo Huang, Xingtong Liu, Shuo Zhang, Sisi Zhong, Yinwei Li, Bin Li, Jing Sun, S. Fang, Huifang Zhou   +12 more
semanticscholar   +1 more source

Yes-Associated Protein Mediates the Transition from Inflammation to Fibrosis in Graves' Orbitopathy

Thyroid, 2023
Background: In Graves' orbitopathy (GO), localized orbital inflammation within the fixed orbit often leads to a fibrotic phenotype resulting in restrictive myopathy or refractory proptosis.
JaeSang Ko, Yong Joon Kim, Soo Hyun Choi, Christopher Seungkyu Lee, Jina Yoon   +4 more
semanticscholar   +1 more source

[Graves' orbitopathy].

Deutsche medizinische Wochenschrift (1946), 2021
Graves' orbitopathy (GO) is an autoimmune orbital disease which is mostly associated with Graves' disease and requires good interdisciplinary cooperation. To minimize irreversible damages a stage-adapted anti-inflammatory therapy is of great importance.Discussion of the latest results of new findings of the pathogenesis, randomized controlled trials on
Eckstein, Anja, Möller, Lars, Führer, Dagmar, Oeverhaus, Michael   +3 more
openaire   +2 more sources

Imaging in Graves' Orbitopathy

Orbit, 2009
In patients with Graves' orbitopathy, magnetic resonance imaging (MRI) is a useful tool to distinguish the acute inflammatory active disease in demonstrating interstitial edema within the extraocular muscles on coronal TIRM-sequences from fibrotic, inactive endstage disease. MRI is the modality of choice to identify active inflammatory changes in order
Kirsch, Eberhard, von Arx, Georg, Hammer, Beat   +2 more
openaire   +2 more sources

[Graves' orbitopathy].

Klinische Monatsblatter fur Augenheilkunde, 2011
Graves' orbitopathy (GO) is part of an autoimmune systemic disease (prevalence of 0.5 - 2%) which is composed of hyperthyroidism, orbitopathy, dermopathy and acropachy. Stimulating antibodies against the TSH receptor plays the central pathogenetic role and high levels indicate the risk of a severe course of the disease. The main symproms of GO comprise
A, Eckstein, J, Esser
openaire   +3 more sources

Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial.

The Lancet Diabetes and Endocrinology, 2021
BACKGROUND A protective action of statins on development of Graves' orbitopathy suggests that statins might be used for treatment of the disease. We aimed to assess the efficacy of the addition of a statin, atorvastatin, to intravenous glucocorticoids ...
G. Lanzolla, E. Sabini, M. Leo, F. Menconi, R. Rocchi, A. Sframeli, P. Piaggi, M. Nardi, C. Marcocci, M. Marinò   +9 more
semanticscholar   +1 more source